Konda Ryuichiro, Sato Hiroshi, Sakai Kiyohide, Abe Yuko, Fujioka Tomoaki
Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan.
Nephron Clin Pract. 2004;98(3):c73-8. doi: 10.1159/000080676.
We determined the urinary levels of vascular endothelial growth factor (VEGF) in patients with reflux nephropathy to elucidate its clinical significance as a predictor of the development of renal damage.
Seventy-two patients (47 boys and 25 girls) aged 10-18 years with reflux nephropathy were studied. Vesicoureteral reflux was resolved surgically in all cases at least 2 years before enrollment. Urinary VEGF, alpha1-microglobulin and albumin levels were determined using morning spot urine samples. Plasma VEGF, serum creatinine and beta2-microglobulin levels were measured simultaneously. The severity of renal scarring and right and left kidney function were assessed by 99mTc dimercaptosuccinic acid renal scan.
No significant correlation was found between the plasma and urinary VEGF levels. Urinary VEGF increased significantly with the increase in severity of renal scarring (p < 0.0001). Urinary VEGF levels correlated significantly with serum beta2-microglobulin (p < 0.002) and urinary alpha1-microglobulin (p < 0.03). No significant correlation of urinary VEGF levels with serum creatinine and urinary albumin levels was found. Nearly 60% of the patients with elevated urinary VEGF had normal levels of serum beta2-microglobulin and/or urinary alpha1-miocroglobulin.
Urinary VEGF level appears to reflect its production in the kidney. Since urinary VEGF shows a propensity to elevate before the increase in serum beta2-microglobulin and/or urinary alpha1-microglobulin, urinary VEGF may serve as an early indicator of the development of reflux nephropathy.
我们测定了反流性肾病患者尿中血管内皮生长因子(VEGF)水平,以阐明其作为肾损伤发展预测指标的临床意义。
研究了72例年龄在10 - 18岁的反流性肾病患者(47例男孩和25例女孩)。所有病例在入组前至少2年已通过手术解决膀胱输尿管反流问题。使用晨尿样本测定尿VEGF、α1 - 微球蛋白和白蛋白水平。同时测定血浆VEGF、血清肌酐和β2 - 微球蛋白水平。通过99mTc二巯基丁二酸肾扫描评估肾瘢痕严重程度以及左右肾功能。
血浆和尿VEGF水平之间未发现显著相关性。尿VEGF随肾瘢痕严重程度增加而显著升高(p < 0.0001)。尿VEGF水平与血清β2 - 微球蛋白(p < 0.002)和尿α1 - 微球蛋白(p < 0.03)显著相关。未发现尿VEGF水平与血清肌酐和尿白蛋白水平有显著相关性。近60%尿VEGF升高的患者血清β2 - 微球蛋白和/或尿α1 - 微球蛋白水平正常。
尿VEGF水平似乎反映了其在肾脏中的产生情况。由于尿VEGF在血清β2 - 微球蛋白和/或尿α1 - 微球蛋白升高之前有升高倾向,尿VEGF可能作为反流性肾病发展的早期指标。